Sarcoidosis is a nonstandardized diagnosis based on three major criteria: a finding of one or more tissue samples with non-necrotizing granulomatous inflammation, a compatible clinical presentation, and the exclusion of alternative sources of granulomatous disease. However, no universally accepted measures to determine diagnostic status have been determined, and patients with sarcoidosis often have an insecure diagnosis. Although sarcoidosis is typically benign, 20%-30% of patients go on to develop progressive, chronic disease. When sarcoidosis needs clinical attention, pharmacotherapy is typically required. Cardiac involvement and advanced pulmonary fibrotic sarcoidosis are among the main contributors to morbidity and mortality for these patients, with liver and kidney failure posing additional concerns.
Are you prepared to address sarcoidosis management for patients based on the most recent clinical practice guidelines? Test your knowledge with this short quiz.
Medscape © 2024 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Romesh Khardori. Fast Five Quiz: Sarcoidosis Management and Treatment - Medscape - Jun 19, 2024.
Comments